Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,168 | 15,416 | 16,030 | 24,991 | 57,555 |
| Marketable Securities | 50,019 | 58,318 | 64,182 | 62,263 | 35,096 |
| TOTAL | $67,030 | $74,214 | $80,713 | $87,686 | $93,647 |
| Non-Current Assets | |||||
| PPE Net | 312 | 351 | 224 | 223 | 195 |
| TOTAL | $312 | $351 | $224 | $223 | $195 |
| Total Assets | $67,342 | $74,565 | $80,937 | $87,909 | $93,842 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,012 | 2,110 | 1,196 | 994 | 1,552 |
| Accrued Expenses | 4,226 | 3,763 | 3,382 | 3,425 | 2,913 |
| TOTAL | $5,238 | $5,873 | $4,578 | $4,419 | $4,465 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,238 | $5,873 | $4,578 | $4,419 | $4,465 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,886 | 3,876 | 3,866 | 3,866 | 3,863 |
| Common Shares | 16 | 15 | 15 | 15 | 15 |
| Retained earnings | -172,587 | -165,154 | -156,675 | -148,837 | -142,274 |
| Other shareholders' equity | 5 | 23 | 3 | 3 | 15 |
| TOTAL | $62,104 | $68,692 | $76,359 | $83,490 | $89,377 |
| Total Liabilities And Equity | $67,342 | $74,565 | $80,937 | $87,909 | $93,842 |